Dagyagnao, Agnes B.
HRN: 17-95-25 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/02/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/02/2025
02/08/2025
IV
2.25gm
Q6
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes